会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明授权
    • Transdermal analyte monitoring systems and methods for analyte detection
    • 透皮分析物监测系统和分析物检测方法
    • US08812071B2
    • 2014-08-19
    • US12043469
    • 2008-03-06
    • Han ChuangJames P. HurleyJoseph Kost
    • Han ChuangJames P. HurleyJoseph Kost
    • A61B5/05A61B5/00A61B5/145A61B5/1486
    • A61B5/0002A61B5/14532A61B5/14546A61B5/1486A61B5/6833
    • Transdermal analyte monitoring systems (TAMS) having increased longevity and improved analyte detection are described herein. Kits for use with the TAMS and methods of using the TAMS and kits are also described. In a preferred embodiment, the TAMS includes a protective, semi-permeable membrane covering the surface of the hydrogel. The protective, semi-permeable membrane contacts with the skin of a user and prevents contamination or fouling of the hydrogel. Optionally, the hydrogel comprises one or more humectants and/or an immobilized enzyme. In another preferred embodiment, the TAMS contains at least one channel or pocket for increasing the amount of oxygen provided to the hydrogel. In one embodiment, a method for improving analyte detection by the TAMS is provided. For example, after the skin porosity is increased by an appropriate pretreatment, a skin preparation wipe is applied to the treated skin area and then the TAMS is applied to the treated area.
    • 本文描述了具有增加的寿命和改进的分析物检测的透皮分析物监测系统(TAMS)。 还描述了与TAMS一起使用的试剂盒和使用TAMS和试剂盒的方法。 在优选实施方案中,TAMS包括覆盖水凝胶表面的保护性半透膜。 保护性半透膜与使用者的皮肤接触并防止水凝胶的污染或结垢。 任选地,水凝胶包含一种或多种湿润剂和/或固定化酶。 在另一个优选的实施方案中,TAMS含有至少一个通道或口袋,用于增加提供给水凝胶的氧气的量。 在一个实施方案中,提供了一种通过TAMS改进分析物检测的方法。 例如,在通过适当的预处理增加皮肤孔隙率之后,将皮肤制剂擦拭物施加到经处理的皮肤区域,然后将TAMS施加到处理区域。
    • 25. 发明申请
    • TRANSDERMAL ANALYTE MONITORING SYSTEMS AND METHODS FOR ANALYTE DETECTION
    • 传感器分析监测系统和分析仪检测方法
    • US20080281178A1
    • 2008-11-13
    • US12043469
    • 2008-03-06
    • Han ChuangJames P. HurleyJoseph Kost
    • Han ChuangJames P. HurleyJoseph Kost
    • A61B5/1486
    • A61B5/0002A61B5/14532A61B5/14546A61B5/1486A61B5/6833
    • Transdermal analyte monitoring systems (TAMS) having increased longevity and improved analyte detection are described herein. Kits for use with the TAMS and methods of using the TAMS and kits are also described. In a preferred embodiment, the TAMS includes a protective, semi-permeable membrane covering the surface of the hydrogel. The protective, semi-permeable membrane contacts with the skin of a user and prevents contamination or fouling of the hydrogel. Optionally, the hydrogel comprises one or more humectants and/or an immobilized enzyme. In another preferred embodiment, the TAMS contains at least one channel or pocket for increasing the amount of oxygen provided to the hydrogel. In one embodiment, a method for improving analyte detection by the TAMS is provided. For example, after the skin porosity is increased by an appropriate pretreatment, a skin preparation wipe is applied to the treated skin area and then the TAMS is applied to the treated area.
    • 本文描述了具有增加的寿命和改进的分析物检测的透皮分析物监测系统(TAMS)。 还描述了与TAMS一起使用的试剂盒和使用TAMS和试剂盒的方法。 在优选实施方案中,TAMS包括覆盖水凝胶表面的保护性半透膜。 保护性半透膜与使用者的皮肤接触并防止水凝胶的污染或结垢。 任选地,水凝胶包含一种或多种湿润剂和/或固定化酶。 在另一个优选的实施方案中,TAMS含有至少一个通道或口袋,用于增加提供给水凝胶的氧气的量。 在一个实施方案中,提供了一种通过TAMS改进分析物检测的方法。 例如,在通过适当的预处理增加皮肤孔隙率之后,将皮肤制剂擦拭物施加到经处理的皮肤区域,然后将TAMS施加到处理区域。
    • 28. 发明授权
    • Composition and method for forming biodegradable implants in situ and uses of these implants
    • 用于在原位形成生物可降解植入物的组合物和方法以及这些植入物的用途
    • US06206920B1
    • 2001-03-27
    • US09180500
    • 1998-12-23
    • Rom EliazJoseph Kost
    • Rom EliazJoseph Kost
    • A61F228
    • A61K9/0024A61K9/204A61L27/18C08L67/04
    • The invention discloses a composition having a mixture of a pharmaceutically, medically or veterinarily acceptable polymer, preferable a poly (lactic-co-glycolic acid) copolymer (PLGA) containing between about 10 and 100 wt. % lactic acid (LA) units, preferably between about 50 and 90 wt. % LA units, and &agr;-(tetrahydrofuranyl)-&ohgr;-hydroxypoly(oxy-1,2-ethandiyl) (glycofurol). Methods of forming solid implants in situ in an animal body, said implants optionally comprising a drug or other biologically active agent, as well as the use of the compositions of the invention in the treatment of animal bodies, are also disclosed.
    • 本发明公开了一种具有药物,医学上或兽医学上可接受的聚合物的混合物的组合物,优选含有约10-100重量%的聚(乳酸 - 共 - 乙醇酸)共聚物(PLGA) %乳酸(LA)单位,优选约50至90重量% %LA单元和α-(四氢呋喃基) - 高 - 羟基聚(氧-1,2-乙二基)(glycofurol)。 还公开了在动物体内原位形成固体植入物的方法,所述植入物任选地包含药物或其它生物活性剂,以及本发明组合物在动物体的治疗中的用途。